ID

34963

Description

TRIal evalUating the Menstrual and Ovarian Function of Young Breast Cancer Patients Treated With a cycloPHosphamide-free Regimen; ODM derived from: https://clinicaltrials.gov/show/NCT02053597

Lien

https://clinicaltrials.gov/show/NCT02053597

Mots-clés

Versions (1)
  1. 06/02/2019 06/02/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

6 février 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Breast Cancer NCT02053597

Anglais

Eligibility Breast Cancer NCT02053597

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. age ≤ 40 years.
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
2. eastern cooperative oncology group (ecog) performance status ≤ 1.
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
3. non-metastatic primary invasive carcinoma of the breast eligible for adjuvant or neoadjuvant chemotherapy.
Description

Invasive carcinoma of breast Primary | Eligibility Adjuvant Chemotherapy | Eligibility Chemotherapy Neoadjuvant

Type de données

boolean

Alias
UMLS CUI [1,1]
C0853879
UMLS CUI [1,2]
C0205225
UMLS CUI [2,1]
C1548635
UMLS CUI [2,2]
C0085533
UMLS CUI [3,1]
C1548635
UMLS CUI [3,2]
C0392920
UMLS CUI [3,3]
C0600558
4. negative estrogen (er) and progesterone receptor (pgr) status.
Description

Estrogen receptor negative status | Progesterone Receptor Status Negative

Type de données

boolean

Alias
UMLS CUI [1]
C1719707
UMLS CUI [2,1]
C1514471
UMLS CUI [2,2]
C1513916
5. baseline left ventricular ejection fraction (lvef) ≥50% measured by an echocardiogram or muga.
Description

Left ventricular ejection fraction Echocardiography | Left ventricular ejection fraction MUGA

Type de données

boolean

Alias
UMLS CUI [1,1]
C0428772
UMLS CUI [1,2]
C0013516
UMLS CUI [2,1]
C0428772
UMLS CUI [2,2]
C0521317
6. interested in maintaining menstrual and/or ovarian function following completion of chemotherapy.
Description

Interest Maintenance Function Menstrual | Interest Maintenance Ovarian function | Status post Chemotherapy Completion

Type de données

boolean

Alias
UMLS CUI [1,1]
C0543488
UMLS CUI [1,2]
C0024501
UMLS CUI [1,3]
C0031843
UMLS CUI [1,4]
C0025344
UMLS CUI [2,1]
C0543488
UMLS CUI [2,2]
C0024501
UMLS CUI [2,3]
C0678879
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0392920
UMLS CUI [3,3]
C0205197
7. known her2/neu status.
Description

HER2/Neu Status Known

Type de données

boolean

Alias
UMLS CUI [1,1]
C1512413
UMLS CUI [1,2]
C0205309
8. negative pregnancy test within 14 days prior to starting chemotherapy.
Description

Pregnancy test negative

Type de données

boolean

Alias
UMLS CUI [1]
C0427780
9. adequate hematologic, hepatic and renal function.
Description

Hematologic function | Liver function | Renal function

Type de données

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
10. signed informed consent.
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. history of prior malignant disease (breast or non-breast) or non-malignant condition which was treated with chemotherapy, pelvic irradiation or any therapy that could potentially affect ovarian function.
Description

Chemotherapy Malignant Neoplasms | Radiotherapy to pelvis Malignant Neoplasms | Chemotherapy Other medical condition | Radiotherapy to pelvis Other medical condition | Therapeutic procedure Affecting Ovarian function

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0006826
UMLS CUI [2,1]
C1536155
UMLS CUI [2,2]
C0006826
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C3843040
UMLS CUI [4,1]
C1536155
UMLS CUI [4,2]
C3843040
UMLS CUI [5,1]
C0087111
UMLS CUI [5,2]
C0392760
UMLS CUI [5,3]
C0678879
2. previous history of amenorrhea > 3 months within the last 2 years (excluding pregnancy).
Description

Amenorrhea Duration

Type de données

boolean

Alias
UMLS CUI [1,1]
C0002453
UMLS CUI [1,2]
C0449238
3. ovarian insufficiency defined as serum fsh > 20 iu/l at the local laboratory, anytime during the menstrual cycle.
Description

Ovarian Insufficiency | Serum follicle stimulating hormone measurement During Menstrual cycle

Type de données

boolean

Alias
UMLS CUI [1]
C1401084
UMLS CUI [2,1]
C0455276
UMLS CUI [2,2]
C0347984
UMLS CUI [2,3]
C0025329
4. any ovarian pathology or abnormalities at the screening pelvic ultrasound, except for functional follicular cysts.
Description

Ovarian Disease Ultrasound pelvis | OVARIAN ABNORMALITY Ultrasound pelvis | Exception Follicular cyst Functional

Type de données

boolean

Alias
UMLS CUI [1,1]
C0029928
UMLS CUI [1,2]
C0948766
UMLS CUI [2,1]
C0149747
UMLS CUI [2,2]
C0948766
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0016427
UMLS CUI [3,3]
C0205245
5. pregnant or breastfeeding patients.
Description

Pregnancy | Breast Feeding

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
6. inability or unwillingness to use effective contraception during and up to 3 months after the last dose of study medication. effective methods include the following: non-hormonal intrauterine device, barrier method - condoms, diaphragm - also in conjugation with spermicidal jelly, or total abstinence. oral, injectable, or implant hormonal contraceptives are not allowed.
Description

Contraceptive methods Unable | Contraceptive methods Unwilling | Intrauterine Devices | Contraception, Barrier | Female Condoms | Vaginal contraceptive diaphragm | Spermicidal Jelly | Total abstinence

Type de données

boolean

Alias
UMLS CUI [1,1]
C0700589
UMLS CUI [1,2]
C1299582
UMLS CUI [2,1]
C0700589
UMLS CUI [2,2]
C0558080
UMLS CUI [3]
C0021900
UMLS CUI [4]
C0004764
UMLS CUI [5]
C0221829
UMLS CUI [6]
C0042241
UMLS CUI [7]
C2985330
UMLS CUI [8]
C0234008
7. concurrent use of any other cytotoxic or hormonal agent, namely gnrh agonists.
Description

Cytotoxic agent | Pharmaceutical Preparations Hormonal | GnRH Agonist

Type de données

boolean

Alias
UMLS CUI [1]
C0304497
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0458083
UMLS CUI [3]
C1518041
8. prior pre-existing peripheral neuropathy of any cause, including diabetes mellitus, alcohol abuse, hiv infection, autoimmune and hereditary neuropathies, amyloidosis, hypothyroidism, vitamin deficiencies.
Description

Peripheral Neuropathy Pre-existing | Diabetes Mellitus | Alcohol abuse | HIV Infection | Autoimmune neuropathy | Inherited neuropathies | Amyloidosis | Hypothyroidism | Vitamin Deficiency

Type de données

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C2347662
UMLS CUI [2]
C0011849
UMLS CUI [3]
C0085762
UMLS CUI [4]
C0019693
UMLS CUI [5]
C2748363
UMLS CUI [6]
C0598589
UMLS CUI [7]
C0002726
UMLS CUI [8]
C0020676
UMLS CUI [9]
C1510471
9. serious cardiac illness, uncontrolled hypertension or medical condition that would affect administration of chemotherapy and compliance to study procedures.
Description

Heart Disease Serious Affecting Chemotherapy | Uncontrolled hypertension Affecting Chemotherapy | Medical condition Affecting Chemotherapy | Heart Disease Serious Affecting Protocol Compliance | Uncontrolled hypertension Affecting Protocol Compliance | Medical condition Affecting Protocol Compliance

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0392760
UMLS CUI [1,4]
C0392920
UMLS CUI [2,1]
C1868885
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C0392920
UMLS CUI [3,1]
C3843040
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C0392920
UMLS CUI [4,1]
C0018799
UMLS CUI [4,2]
C0205404
UMLS CUI [4,3]
C0392760
UMLS CUI [4,4]
C0525058
UMLS CUI [5,1]
C1868885
UMLS CUI [5,2]
C0392760
UMLS CUI [5,3]
C0525058
UMLS CUI [6,1]
C3843040
UMLS CUI [6,2]
C0392760
UMLS CUI [6,3]
C0525058
10. known sensitivity to any of the study medications.
Description

Hypersensitivity Investigational New Drugs

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
Retour au début de la page

Similar models

Eligibility Breast Cancer NCT02053597

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
1. age ≤ 40 years.
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
2. eastern cooperative oncology group (ecog) performance status ≤ 1.
boolean
C1520224 (UMLS CUI [1])
Invasive carcinoma of breast Primary | Eligibility Adjuvant Chemotherapy | Eligibility Chemotherapy Neoadjuvant
Item
3. non-metastatic primary invasive carcinoma of the breast eligible for adjuvant or neoadjuvant chemotherapy.
boolean
C0853879 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C1548635 (UMLS CUI [2,1])
C0085533 (UMLS CUI [2,2])
C1548635 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
C0600558 (UMLS CUI [3,3])
Estrogen receptor negative status | Progesterone Receptor Status Negative
Item
4. negative estrogen (er) and progesterone receptor (pgr) status.
boolean
C1719707 (UMLS CUI [1])
C1514471 (UMLS CUI [2,1])
C1513916 (UMLS CUI [2,2])
Left ventricular ejection fraction Echocardiography | Left ventricular ejection fraction MUGA
Item
5. baseline left ventricular ejection fraction (lvef) ≥50% measured by an echocardiogram or muga.
boolean
C0428772 (UMLS CUI [1,1])
C0013516 (UMLS CUI [1,2])
C0428772 (UMLS CUI [2,1])
C0521317 (UMLS CUI [2,2])
Interest Maintenance Function Menstrual | Interest Maintenance Ovarian function | Status post Chemotherapy Completion
Item
6. interested in maintaining menstrual and/or ovarian function following completion of chemotherapy.
boolean
C0543488 (UMLS CUI [1,1])
C0024501 (UMLS CUI [1,2])
C0031843 (UMLS CUI [1,3])
C0025344 (UMLS CUI [1,4])
C0543488 (UMLS CUI [2,1])
C0024501 (UMLS CUI [2,2])
C0678879 (UMLS CUI [2,3])
C0231290 (UMLS CUI [3,1])
C0392920 (UMLS CUI [3,2])
C0205197 (UMLS CUI [3,3])
HER2/Neu Status Known
Item
7. known her2/neu status.
boolean
C1512413 (UMLS CUI [1,1])
C0205309 (UMLS CUI [1,2])
Pregnancy test negative
Item
8. negative pregnancy test within 14 days prior to starting chemotherapy.
boolean
C0427780 (UMLS CUI [1])
Hematologic function | Liver function | Renal function
Item
9. adequate hematologic, hepatic and renal function.
boolean
C0221130 (UMLS CUI [1])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Informed Consent
Item
10. signed informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Chemotherapy Malignant Neoplasms | Radiotherapy to pelvis Malignant Neoplasms | Chemotherapy Other medical condition | Radiotherapy to pelvis Other medical condition | Therapeutic procedure Affecting Ovarian function
Item
1. history of prior malignant disease (breast or non-breast) or non-malignant condition which was treated with chemotherapy, pelvic irradiation or any therapy that could potentially affect ovarian function.
boolean
C0392920 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
C1536155 (UMLS CUI [2,1])
C0006826 (UMLS CUI [2,2])
C0392920 (UMLS CUI [3,1])
C3843040 (UMLS CUI [3,2])
C1536155 (UMLS CUI [4,1])
C3843040 (UMLS CUI [4,2])
C0087111 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C0678879 (UMLS CUI [5,3])
Amenorrhea Duration
Item
2. previous history of amenorrhea > 3 months within the last 2 years (excluding pregnancy).
boolean
C0002453 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
Ovarian Insufficiency | Serum follicle stimulating hormone measurement During Menstrual cycle
Item
3. ovarian insufficiency defined as serum fsh > 20 iu/l at the local laboratory, anytime during the menstrual cycle.
boolean
C1401084 (UMLS CUI [1])
C0455276 (UMLS CUI [2,1])
C0347984 (UMLS CUI [2,2])
C0025329 (UMLS CUI [2,3])
Ovarian Disease Ultrasound pelvis | OVARIAN ABNORMALITY Ultrasound pelvis | Exception Follicular cyst Functional
Item
4. any ovarian pathology or abnormalities at the screening pelvic ultrasound, except for functional follicular cysts.
boolean
C0029928 (UMLS CUI [1,1])
C0948766 (UMLS CUI [1,2])
C0149747 (UMLS CUI [2,1])
C0948766 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0016427 (UMLS CUI [3,2])
C0205245 (UMLS CUI [3,3])
Pregnancy | Breast Feeding
Item
5. pregnant or breastfeeding patients.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Contraceptive methods Unable | Contraceptive methods Unwilling | Intrauterine Devices | Contraception, Barrier | Female Condoms | Vaginal contraceptive diaphragm | Spermicidal Jelly | Total abstinence
Item
6. inability or unwillingness to use effective contraception during and up to 3 months after the last dose of study medication. effective methods include the following: non-hormonal intrauterine device, barrier method - condoms, diaphragm - also in conjugation with spermicidal jelly, or total abstinence. oral, injectable, or implant hormonal contraceptives are not allowed.
boolean
C0700589 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
C0700589 (UMLS CUI [2,1])
C0558080 (UMLS CUI [2,2])
C0021900 (UMLS CUI [3])
C0004764 (UMLS CUI [4])
C0221829 (UMLS CUI [5])
C0042241 (UMLS CUI [6])
C2985330 (UMLS CUI [7])
C0234008 (UMLS CUI [8])
Cytotoxic agent | Pharmaceutical Preparations Hormonal | GnRH Agonist
Item
7. concurrent use of any other cytotoxic or hormonal agent, namely gnrh agonists.
boolean
C0304497 (UMLS CUI [1])
C0013227 (UMLS CUI [2,1])
C0458083 (UMLS CUI [2,2])
C1518041 (UMLS CUI [3])
Peripheral Neuropathy Pre-existing | Diabetes Mellitus | Alcohol abuse | HIV Infection | Autoimmune neuropathy | Inherited neuropathies | Amyloidosis | Hypothyroidism | Vitamin Deficiency
Item
8. prior pre-existing peripheral neuropathy of any cause, including diabetes mellitus, alcohol abuse, hiv infection, autoimmune and hereditary neuropathies, amyloidosis, hypothyroidism, vitamin deficiencies.
boolean
C0031117 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C0011849 (UMLS CUI [2])
C0085762 (UMLS CUI [3])
C0019693 (UMLS CUI [4])
C2748363 (UMLS CUI [5])
C0598589 (UMLS CUI [6])
C0002726 (UMLS CUI [7])
C0020676 (UMLS CUI [8])
C1510471 (UMLS CUI [9])
Heart Disease Serious Affecting Chemotherapy | Uncontrolled hypertension Affecting Chemotherapy | Medical condition Affecting Chemotherapy | Heart Disease Serious Affecting Protocol Compliance | Uncontrolled hypertension Affecting Protocol Compliance | Medical condition Affecting Protocol Compliance
Item
9. serious cardiac illness, uncontrolled hypertension or medical condition that would affect administration of chemotherapy and compliance to study procedures.
boolean
C0018799 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0392760 (UMLS CUI [1,3])
C0392920 (UMLS CUI [1,4])
C1868885 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C0392920 (UMLS CUI [2,3])
C3843040 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C0392920 (UMLS CUI [3,3])
C0018799 (UMLS CUI [4,1])
C0205404 (UMLS CUI [4,2])
C0392760 (UMLS CUI [4,3])
C0525058 (UMLS CUI [4,4])
C1868885 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C0525058 (UMLS CUI [5,3])
C3843040 (UMLS CUI [6,1])
C0392760 (UMLS CUI [6,2])
C0525058 (UMLS CUI [6,3])
Hypersensitivity Investigational New Drugs
Item
10. known sensitivity to any of the study medications.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial